# Fate Therapeutics Inc: Form 8-K, filed Dec 7, 2020

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2020-12-07
- Accepted by EDGAR: Dec 7, 2020, 09:00 ET
- Period: 2020-12-04
- Accession: 0001564590-20-056247
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000156459020056247/fate-8k_20201204.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000156459020056247/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000156459020056247/fate-8k_20201204.htm

Filed Dec 7, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-056247. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
